CLINICAL_TRIALS
trial_result
· 2017-12-13
Clinical Trial Update: Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea [Phase 3]
Summary
Phase 3 trial update evaluating a booster dose of IMOJEV one year after primary immunization in healthy children in South Korea.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Japanese Encephalitis | Phase 3 | Status: COMPLETED | Results posted: 2017-12-13